Company: ARTL
Filing Date: 2025-08-07
Form Type: 8-K
Source: 0001640334-25-001375
Chunk: 3

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-07
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                            
  4.1 *            Common Stock Warrant issued to ABK Labs, Inc., dated August 1, 2025                                    
  10.1             Consulting Agreement by and between Artelo Biosciences, Inc. and ABK Labs, Inc., dated August 1, 2025  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

* Portions of this exhibit have been omitted pursuant to Item 601 of Regulation S-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: August 7, 2025      ARTELO BIOSCIENCES, INC.                                             
 ─────────────────────────────────────────────────────────────────────────────────────────────────
                            /s/ Gregory D. Gorgas                                                
                            Name:                         Gregory D. Gorgas                      
                            Title:                        Chief Executive Officer and President  

   4